Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.41 |
| ▸ | PDE3B | Q13370 | 2/20 | 0.40 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.40 |
| ▸ | NPFFR1 | Q9GZQ6 | 1/20 | 0.39 |
| ▸ | NPFFR2 | Q9Y5X5 | 1/20 | 0.39 |
| ▸ | ELANE | P08246 | 1/20 | 0.38 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | GPR3 | P46089 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | PDE2A | O00408 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3959059 | 0.98 | CYP1A2 (0.42) | CYP1A2CYP2A6ALDH1A1BACE1PDE3B | |
| SCHEMBL826491 | 0.78 | CYP1A2 (0.57) | CYP1A2CYP2A6ALDH1A1BACE1PDE3B | |
| SCHEMBL4615123 | 0.78 | ACHE (0.48) | CYP1A2ALDH1A1BACE1L3MBTL1HPGD | |
| SCHEMBL29958192 | 0.76 | HTR3A (0.34) | CYP1A2ALDH1A1BACE1ELANEGPR3 | |
| SCHEMBL23674668 | 0.75 | CYP1A2 (0.44) | CYP1A2CYP2A6ALDH1A1BACE1PDE3B | |
| SCHEMBL13049644 | 0.75 | BACE1 (0.60) | CYP1A2BACE1 | |
| SCHEMBL19044620 | 0.75 | CYP1A2 (0.44) | CYP1A2CYP2A6ALDH1A1BACE1PDE3B | |
| SCHEMBL7219172 | 0.75 | CYP1A2 (0.44) | CYP1A2CYP2A6ALDH1A1BACE1PDE3B | |
| SCHEMBL5540363 | 0.75 | CYP1A2 (0.44) | CYP1A2CYP2A6ALDH1A1BACE1PDE3B | |
| SCHEMBL31756394 | 0.75 | PDE7A (0.36) | CYP1A2BACE1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102140078-A | Improved scraup method for preparing quinoline or quinoline derivatives | LI MOWEI | 2011-08-03 | — | — | CN | claimed |
| CN-117986220-A | Method for preparing substituted chromanone derivative | 杭州杜易科技有限公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-114222734-B | Method for preparing substituted chromanone derivative | 杭州杜易科技有限公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-116199876-A | Polyphenylene ether resin and process for producing the same | 中化学科学技术研究有限公司 | 2023-06-02 | — | — | CN | disclosed |
| CN-114222734-A | Method for preparing substituted chromanone derivative | 杭州杜易科技有限公司 | 2022-03-22 | — | — | CN | disclosed |
| WO-2022008896-A1 | TRIAZOLE DERIVATIVES AND THEIR USE AS TANKYRASE INHIBITORS. | GOLDING, LOUISE (GB) | 2022-01-13 | — | — | WO | disclosed |
| CN-106009788-B | Coating liquid for forming coating film, method for producing same, and method for producing substrate with coating film | 日挥触媒化成株式会社 | 2020-06-16 | — | — | CN | disclosed |
| CN-106497400-B | Coating liquid for forming coating film, method for producing coating liquid for forming coating film, and substrate with coating film | 日挥触媒化成株式会社 | 2020-04-03 | — | — | CN | disclosed |
| CN-106497400-A | Overlay film formation coating fluid, the manufacture method of overlay film formation coating fluid and the base material with overlay film | 日挥触媒化成株式会社 | 2017-03-15 | — | — | CN | disclosed |
| CN-106009788-A | COATING SOLUTION FOR FORMING FILM, METHOD FOR PRODUCING THE COATING SOLUTION AND METHOD FOR PRODUCING SUBSTRATE WITH FILM | 日挥触媒化成株式会社 | 2016-10-12 | — | — | CN | disclosed |
| US-7507749-B2 | Antitumor agents | WAYNE STATE UNIVERSITY (US) | 2009-03-24 | — | — | US | disclosed |
| US-20090076073-A1 | THERAPEUTIC AMIDES | WAYNE STATE UNIVERSITY | 2009-03-19 | — | — | US | disclosed |
| US-20090076073-A1 | THERAPEUTIC AMIDES | WAYNE STATE UNIVERSITY | 2009-03-19 | — | — | US | disclosed |
| US-20070232643-A1 | Quinoline derivative, e.g. 2[4-(7-chloroquinolin-2-yloxy)phenoxy]propionic acid sodium salt; anticarcinogenic, antitumor agent; colon, breast, melanoma, pancreatic cancer or adenocarcinoma; melanoma, or leukemia; based on herbicides | WAYNE STATE UNIVERSITY | 2007-10-04 | — | — | US | disclosed |
| US-20070232643-A1 | Quinoline derivative, e.g. 2[4-(7-chloroquinolin-2-yloxy)phenoxy]propionic acid sodium salt; anticarcinogenic, antitumor agent; colon, breast, melanoma, pancreatic cancer or adenocarcinoma; melanoma, or leukemia; based on herbicides | WAYNE STATE UNIVERSITY | 2007-10-04 | — | — | US | disclosed |
| US-7262212-B2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-08-28 | — | — | US | disclosed |
| US-7241894-B2 | Antitumor agents | WAYNE STATE UNIVERSITY (US) | 2007-07-10 | — | — | US | disclosed |
| US-7241894-B2 | Antitumor agents | WAYNE STATE UNIVERSITY (US) | 2007-07-10 | — | — | US | disclosed |
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-05-04 | — | — | US | disclosed |
| EP-1555267-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-07-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | NR2C2, NR4A3, NR4A2 | CYP1A2 659/4885CYP2A6 1119/4885ALDH1A1 355/4885 |
| US-20070232643-A1 | Quinoline derivative, e.g. 2[4-(7-chloroquinolin-2-yloxy)phenoxy]propionic acid sodium salt; anticarcinogenic, antitumor agent; colon, breast, melanoma, pancreatic cancer or adenocarcinoma; melanoma, or leukemia; based on herbicides | NRAS, KRAS, BRAF | CYP1A2 1414/4885CYP2A6 1547/4885ALDH1A1 383/4885 |
| US-20090076073-A1 | THERAPEUTIC AMIDES | HDAC5, HDAC6, ASAH2 | CYP1A2 3511/4885CYP2A6 3372/4885ALDH1A1 1259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.